121 related articles for article (PubMed ID: 38423093)
41. Value of Contrast-Enhanced Ultrasound in the Differential Diagnosis of Focal Splenic Lesions.
Yang R; Lu Q; Xu J; Huang J; Gao B; Zhang H; Zhou J; Du L; Yan F
Cancer Manag Res; 2021; 13():2947-2958. PubMed ID: 33833578
[TBL] [Abstract][Full Text] [Related]
42. [Diagnostic value of contrast-enhanced ultrasound in breast lesions of BI-RADS 4].
Liang YC; Jia CM; Xue Y; Lü Q; Chen F; Wang JJ
Zhonghua Yi Xue Za Zhi; 2018 May; 98(19):1498-1502. PubMed ID: 29804418
[No Abstract] [Full Text] [Related]
43. The application value of contrast-enhanced ultrasound in the differential diagnosis of pancreatic solid-cystic lesions.
Xu M; Xie XY; Liu GJ; Xu HX; Xu ZF; Huang GL; Chen PF; Luo J; Lü MD
Eur J Radiol; 2012 Jul; 81(7):1432-7. PubMed ID: 21477957
[TBL] [Abstract][Full Text] [Related]
44. Comparison of magnetic resonance imaging (MRI) and contrast-enhanced ultrasound (CEUS) in the evaluation of unclear solid renal lesions.
Rübenthaler J; Paprottka K; Marcon J; Hameister E; Hoffmann K; Joiko N; Reiser M; Clevert DA
Clin Hemorheol Microcirc; 2016; 64(4):757-763. PubMed ID: 27767985
[TBL] [Abstract][Full Text] [Related]
45. Ultrasound-based "CEUS-Bosniak"classification for cystic renal lesions: an 8-year clinical experience.
Herms E; Weirich G; Maurer T; Wagenpfeil S; Preuss S; Sauter A; Heck M; Gärtner A; Hauner K; Autenrieth M; Kübler HP; Holzapfel K; Schwarz-Boeger U; Heemann U; Slotta-Huspenina J; Stock KF
World J Urol; 2023 Mar; 41(3):679-685. PubMed ID: 35986781
[TBL] [Abstract][Full Text] [Related]
46. The value of contrast-enhanced ultrasound in the diagnosis of BI-RADS-US 4a lesions less than 2 cm in diameter.
Yu MQ; Zhang LL; Jiang LP; Zhou AY
Clin Hemorheol Microcirc; 2023; 83(3):195-205. PubMed ID: 35599475
[TBL] [Abstract][Full Text] [Related]
47. The kinetic quantitative characteristics of non-mass breast lesions with contrast-enhanced ultrasound: a prospective study.
Cai YY; Du YC; Zhao L; Hu WJ; Bai Y; Chen A; Du LF; Li F
Br J Radiol; 2023 Dec; 96(1152):20221002. PubMed ID: 37660395
[TBL] [Abstract][Full Text] [Related]
48. Contrast-enhanced ultrasound (CEUS) has excellent diagnostic accuracy in differentiating focal liver lesions: results from a Swiss tertiary gastroenterological centre.
Sawatzki M; Meyenberger C; Brand S; Semela D
Swiss Med Wkly; 2019 Jun; 149():w20087. PubMed ID: 31256416
[TBL] [Abstract][Full Text] [Related]
49. Feasibility and Safety of Contrast-Enhanced Ultrasound of the Neonatal Brain: A Prospective Study Using MRI as the Reference Standard.
Squires JH; Beluk NH; Lee VK; Yanowitz TD; Gumus S; Subramanian S; Panigrahy A
AJR Am J Roentgenol; 2022 Jan; 218(1):152-161. PubMed ID: 34286594
[No Abstract] [Full Text] [Related]
50. A Pivotal Study of Optoacoustic Imaging to Diagnose Benign and Malignant Breast Masses: A New Evaluation Tool for Radiologists.
Neuschler EI; Butler R; Young CA; Barke LD; Bertrand ML; Böhm-Vélez M; Destounis S; Donlan P; Grobmyer SR; Katzen J; Kist KA; Lavin PT; Makariou EV; Parris TM; Schilling KJ; Tucker FL; Dogan BE
Radiology; 2018 May; 287(2):398-412. PubMed ID: 29178816
[TBL] [Abstract][Full Text] [Related]
51. Diagnosis of Benign and Malignant BI-RADS 4 Breast Masses by Contrastenhanced Ultrasound Combined with Shear Wave Elastography.
Weng L; Yu M
Curr Med Imaging; 2023 Oct; ():. PubMed ID: 37921152
[TBL] [Abstract][Full Text] [Related]
52. Papillary breast lesions detected using conventional ultrasound and contrast-enhanced ultrasound: Imaging characteristics and associations with malignancy.
Niu RL; Li SY; Wang B; Jiang Y; Liu G; Wang ZL
Eur J Radiol; 2021 Aug; 141():109788. PubMed ID: 34091133
[TBL] [Abstract][Full Text] [Related]
53. The Value of Chinese Thyroid Imaging Report and Data System Combined With Contrast-Enhanced Ultrasound Scoring in Differential Diagnosis of Benign and Malignant Thyroid Nodules.
Cao H; Fan Q; Zhuo S; Qi T; Sun H; Rong X; Xiao X; Zhang W; Zhu L; Wang L
J Ultrasound Med; 2022 Jul; 41(7):1753-1761. PubMed ID: 34709672
[TBL] [Abstract][Full Text] [Related]
54. Value of contrast-enhanced ultrasound area ratio in identifying benign and malignant small breast masses.
Wang W; Zheng Y; Wu XF; Zhao D; Hou LZ; Shi F; Liu JJ; Dong FL
Gland Surg; 2020 Oct; 9(5):1486-1494. PubMed ID: 33224823
[TBL] [Abstract][Full Text] [Related]
55. Contrast-enhanced ultrasound for characterizing renal masses.
Bertolotto M; Bucci S; Valentino M; Currò F; Sachs C; Cova MA
Eur J Radiol; 2018 Aug; 105():41-48. PubMed ID: 30017297
[TBL] [Abstract][Full Text] [Related]
56. Determining whether the diagnostic value of B-ultrasound combined with contrast-enhanced ultrasound and shear wave elastography in breast mass-like and non-mass-like lesions differs: a diagnostic test.
Li SY; Niu RL; Wang B; Jiang Y; Li JN; Liu G; Wang ZL
Gland Surg; 2023 Feb; 12(2):282-296. PubMed ID: 36915819
[TBL] [Abstract][Full Text] [Related]
57. Role of Superb Microvascular Imaging in Differentiating Between Malignant and Benign Solid Breast Masses.
Diao X; Zhan J; Chen L; Chen Y; Cao H
Clin Breast Cancer; 2020 Dec; 20(6):e786-e793. PubMed ID: 32863154
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic efficacy of contrast-enhanced ultrasound for small renal masses.
Oh TH; Lee YH; Seo IY
Korean J Urol; 2014 Sep; 55(9):587-92. PubMed ID: 25237460
[TBL] [Abstract][Full Text] [Related]
59. A Nomogram for Enhancing the Diagnostic Effectiveness of Solid Breast BI-RADS 3-5 Masses to Determine Malignancy Based on Imaging Aspects of Conventional Ultrasonography and Contrast-Enhanced Ultrasound.
Yan M; Peng C; He D; Xu D; Yang C
Clin Breast Cancer; 2023 Oct; 23(7):693-703. PubMed ID: 37394416
[TBL] [Abstract][Full Text] [Related]
60. Quantification of dynamic contrast-enhanced ultrasound (CEUS) in non-cystic breast lesions using external perfusion software.
Jung EM; Jung F; Stroszczynski C; Wiesinger I
Sci Rep; 2021 Sep; 11(1):17677. PubMed ID: 34480040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
